Profiling small RNAs in fecal immunochemical tests: is it possible?

Abstract Fecal microRNAs represent promising molecules with potential clinical interest as non-invasive diagnostic and prognostic biomarkers. Colorectal cancer (CRC) screening based on the fecal immunochemical test (FIT) is an effective tool for prevention of cancer development. However, due to the...

Full description

Bibliographic Details
Main Authors: Einar Birkeland, Giulio Ferrero, Barbara Pardini, Sinan U. Umu, Sonia Tarallo, Sara Bulfamante, Geir Hoff, Carlo Senore, Trine B Rounge, Alessio Naccarati
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Molecular Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12943-023-01869-w
_version_ 1827635331079340032
author Einar Birkeland
Giulio Ferrero
Barbara Pardini
Sinan U. Umu
Sonia Tarallo
Sara Bulfamante
Geir Hoff
Carlo Senore
Trine B Rounge
Alessio Naccarati
author_facet Einar Birkeland
Giulio Ferrero
Barbara Pardini
Sinan U. Umu
Sonia Tarallo
Sara Bulfamante
Geir Hoff
Carlo Senore
Trine B Rounge
Alessio Naccarati
author_sort Einar Birkeland
collection DOAJ
description Abstract Fecal microRNAs represent promising molecules with potential clinical interest as non-invasive diagnostic and prognostic biomarkers. Colorectal cancer (CRC) screening based on the fecal immunochemical test (FIT) is an effective tool for prevention of cancer development. However, due to the poor sensitivity of FIT especially for premalignant lesions, there is a need for implementation of complementary tests. Improving the identification of individuals who would benefit from further investigation with colonoscopy using molecular analysis, such as miRNA profiling of FIT samples, would be ideal due to their widespread use. In the present study, we assessed the feasibility of applying small RNA sequencing to measure human miRNAs in FIT leftover buffer in samples from two European screening populations. We showed robust detection of miRNAs with profiles similar to those obtained from specimens sampled using the established protocol of RNA stabilizing buffers, or in long-term archived samples. Detected miRNAs exhibited differential abundances for CRC, advanced adenoma, and control samples that were consistent for FIT and RNA-stabilizing buffers. Interestingly, the sequencing data also allowed for concomitant evaluation of small RNA-based microbial profiles. We demonstrated that it is possible to explore the human miRNome in FIT leftover samples across populations and envision that the analysis of small RNA biomarkers can complement the FIT in large scale screening settings.
first_indexed 2024-03-09T15:26:16Z
format Article
id doaj.art-5d377c62ad044a339f559ffcc1c5b51a
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-03-09T15:26:16Z
publishDate 2023-10-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-5d377c62ad044a339f559ffcc1c5b51a2023-11-26T12:31:33ZengBMCMolecular Cancer1476-45982023-10-012211710.1186/s12943-023-01869-wProfiling small RNAs in fecal immunochemical tests: is it possible?Einar Birkeland0Giulio Ferrero1Barbara Pardini2Sinan U. Umu3Sonia Tarallo4Sara Bulfamante5Geir Hoff6Carlo Senore7Trine B Rounge8Alessio Naccarati9Centre for Bioinformatics, Department of Informatics, University of OsloDepartment of Clinical and Biological Sciences, University of TurinItalian Institute for Genomic Medicine (IIGM)Department of Pathology, Institute of Clinical Medicine, University of OsloItalian Institute for Genomic Medicine (IIGM)Epidemiology and Screening Unit-CPO, University Hospital Città della Salute e della ScienzaSection for colorectal cancer screening, Cancer Registry of Norway, Oslo University HospitalEpidemiology and Screening Unit-CPO, University Hospital Città della Salute e della ScienzaDepartment of Research, Cancer Registry of NorwayItalian Institute for Genomic Medicine (IIGM)Abstract Fecal microRNAs represent promising molecules with potential clinical interest as non-invasive diagnostic and prognostic biomarkers. Colorectal cancer (CRC) screening based on the fecal immunochemical test (FIT) is an effective tool for prevention of cancer development. However, due to the poor sensitivity of FIT especially for premalignant lesions, there is a need for implementation of complementary tests. Improving the identification of individuals who would benefit from further investigation with colonoscopy using molecular analysis, such as miRNA profiling of FIT samples, would be ideal due to their widespread use. In the present study, we assessed the feasibility of applying small RNA sequencing to measure human miRNAs in FIT leftover buffer in samples from two European screening populations. We showed robust detection of miRNAs with profiles similar to those obtained from specimens sampled using the established protocol of RNA stabilizing buffers, or in long-term archived samples. Detected miRNAs exhibited differential abundances for CRC, advanced adenoma, and control samples that were consistent for FIT and RNA-stabilizing buffers. Interestingly, the sequencing data also allowed for concomitant evaluation of small RNA-based microbial profiles. We demonstrated that it is possible to explore the human miRNome in FIT leftover samples across populations and envision that the analysis of small RNA biomarkers can complement the FIT in large scale screening settings.https://doi.org/10.1186/s12943-023-01869-wSmall RNA sequencingFecal immunochemical test (FIT)Colorectal cancer screeningStool biomarkersMicrobiomemicroRNAs
spellingShingle Einar Birkeland
Giulio Ferrero
Barbara Pardini
Sinan U. Umu
Sonia Tarallo
Sara Bulfamante
Geir Hoff
Carlo Senore
Trine B Rounge
Alessio Naccarati
Profiling small RNAs in fecal immunochemical tests: is it possible?
Molecular Cancer
Small RNA sequencing
Fecal immunochemical test (FIT)
Colorectal cancer screening
Stool biomarkers
Microbiome
microRNAs
title Profiling small RNAs in fecal immunochemical tests: is it possible?
title_full Profiling small RNAs in fecal immunochemical tests: is it possible?
title_fullStr Profiling small RNAs in fecal immunochemical tests: is it possible?
title_full_unstemmed Profiling small RNAs in fecal immunochemical tests: is it possible?
title_short Profiling small RNAs in fecal immunochemical tests: is it possible?
title_sort profiling small rnas in fecal immunochemical tests is it possible
topic Small RNA sequencing
Fecal immunochemical test (FIT)
Colorectal cancer screening
Stool biomarkers
Microbiome
microRNAs
url https://doi.org/10.1186/s12943-023-01869-w
work_keys_str_mv AT einarbirkeland profilingsmallrnasinfecalimmunochemicaltestsisitpossible
AT giulioferrero profilingsmallrnasinfecalimmunochemicaltestsisitpossible
AT barbarapardini profilingsmallrnasinfecalimmunochemicaltestsisitpossible
AT sinanuumu profilingsmallrnasinfecalimmunochemicaltestsisitpossible
AT soniatarallo profilingsmallrnasinfecalimmunochemicaltestsisitpossible
AT sarabulfamante profilingsmallrnasinfecalimmunochemicaltestsisitpossible
AT geirhoff profilingsmallrnasinfecalimmunochemicaltestsisitpossible
AT carlosenore profilingsmallrnasinfecalimmunochemicaltestsisitpossible
AT trinebrounge profilingsmallrnasinfecalimmunochemicaltestsisitpossible
AT alessionaccarati profilingsmallrnasinfecalimmunochemicaltestsisitpossible